Within the established crosstalk between ERα and MAPK signaling axes, constitutive activation of the MAPK pathway could bypass ERα inhibition, eventually promoting tumor cell growth, proliferation and resistance to ETs [10,41,42]. The gene discussed is ESR1; the disease is neoplasm.